ZA977597B - Spirocyclic dopamine receptor subtype ligands - Google Patents
Spirocyclic dopamine receptor subtype ligandsInfo
- Publication number
- ZA977597B ZA977597B ZA977597A ZA977597A ZA977597B ZA 977597 B ZA977597 B ZA 977597B ZA 977597 A ZA977597 A ZA 977597A ZA 977597 A ZA977597 A ZA 977597A ZA 977597 B ZA977597 B ZA 977597B
- Authority
- ZA
- South Africa
- Prior art keywords
- spirocyclic
- dopamine receptor
- receptor subtype
- subtype ligands
- ligands
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/06—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals
- C07D295/073—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals with the ring nitrogen atoms and the substituents separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/10—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms
- C07D295/112—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms with the ring nitrogen atoms and the doubly bound oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D295/155—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/94—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom spiro-condensed with carbocyclic rings or ring systems, e.g. griseofulvins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D333/58—Radicals substituted by nitrogen atoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Neurosurgery (AREA)
- Psychology (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Furan Compounds (AREA)
- Indole Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2479796P | 1996-08-26 | 1996-08-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA977597B true ZA977597B (en) | 1999-02-25 |
Family
ID=21822443
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA977597A ZA977597B (en) | 1996-08-26 | 1997-08-25 | Spirocyclic dopamine receptor subtype ligands |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US6664258B1 (de) |
| EP (1) | EP0925291B1 (de) |
| JP (1) | JP3152941B2 (de) |
| AP (1) | AP9701075A0 (de) |
| AR (1) | AR013836A1 (de) |
| AT (1) | ATE311377T1 (de) |
| AU (1) | AU3632297A (de) |
| CA (1) | CA2264549C (de) |
| CO (1) | CO4560554A1 (de) |
| DE (1) | DE69734774D1 (de) |
| GT (1) | GT199700096A (de) |
| HN (1) | HN1997000117A (de) |
| HR (1) | HRP970455A2 (de) |
| ID (1) | ID18076A (de) |
| IL (1) | IL128050A0 (de) |
| IS (1) | IS4969A (de) |
| MA (1) | MA26437A1 (de) |
| PA (1) | PA8436501A1 (de) |
| PE (1) | PE108498A1 (de) |
| TN (1) | TNSN97143A1 (de) |
| WO (1) | WO1998008835A1 (de) |
| ZA (1) | ZA977597B (de) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0953567A3 (de) | 1998-04-29 | 2003-04-02 | Pfizer Products Inc. | Bizyklisch substituierte Piperazin-, Piperidin- und Tetrahydropyridin Derivate, deren Herstellung und deren Verwendung als Mittel mit zentraler dopaminerger (Dopamin D4 Rezeptor) Aktivität |
| AU754529B2 (en) * | 1998-09-22 | 2002-11-21 | Yamanouchi Pharmaceutical Co., Ltd. | Cyanophenyl derivatives |
| EP1177792A3 (de) * | 2000-07-27 | 2002-10-23 | Pfizer Products Inc. | Dopamin-d4-ligande zur behandlung von gaudi-suchenden krankheiten |
| GB0328906D0 (en) | 2003-12-12 | 2004-01-14 | Syngenta Participations Ag | Chemical compounds |
| CN106831541B (zh) | 2011-11-18 | 2019-09-06 | 赫普泰雅治疗有限公司 | 毒蕈碱性m1受体激动剂 |
| GB201513743D0 (en) | 2015-08-03 | 2015-09-16 | Heptares Therapeutics Ltd | Muscarinic agonists |
| GB201617454D0 (en) * | 2016-10-14 | 2016-11-30 | Heptares Therapeutics Limited | Pharmaceutical compounds |
| GB201810239D0 (en) | 2018-06-22 | 2018-08-08 | Heptares Therapeutics Ltd | Pharmaceutical compounds |
| GB201819960D0 (en) | 2018-12-07 | 2019-01-23 | Heptares Therapeutics Ltd | Pharmaceutical compounds |
| GB202020191D0 (en) | 2020-12-18 | 2021-02-03 | Heptares Therapeutics Ltd | Pharmaceutical compounds |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE758919A (fr) | 1969-11-15 | 1971-05-13 | Merck Patent Gmbh | Spiro-composes |
| US3932425A (en) | 1974-04-12 | 1976-01-13 | The Upjohn Company | Benzospiran derivatives |
| US4010201A (en) | 1974-04-12 | 1977-03-01 | The Upjohn Company | Organic compounds |
| US4025558A (en) | 1974-04-12 | 1977-05-24 | The Upjohn Company | Organic compounds |
| DE2818329A1 (de) | 1978-04-26 | 1979-11-08 | Yoshitomi Pharmaceutical | Spiro eckige klammer auf cyclohexan- 1,9'-thioxanthen eckige klammer zu -verbindungen |
| CA2091204C (en) | 1992-03-11 | 1997-04-08 | Ronald J. Mattson | Antiischemic-piperazinyl and piperidinyl-cyclohexanes |
| ES2133416T3 (es) | 1992-10-23 | 1999-09-16 | Merck Sharp & Dohme | Ligandos de subtipos de receptores de dopamina. |
| GB9317631D0 (en) | 1993-08-25 | 1993-10-13 | Bxl Plastics Ltd | Multi-layered composite |
| US5403846A (en) | 1993-11-22 | 1995-04-04 | Merck & Co., Inc. | Spirocycles |
| AU691296B2 (en) | 1994-05-06 | 1998-05-14 | Pharmacopeia Drug Discovery, Inc. | Combinatorial dihydrobenzopyran library |
| GB9410031D0 (en) | 1994-05-19 | 1994-07-06 | Merck Sharp & Dohme | Therapeutic agents |
-
1997
- 1997-08-08 JP JP51143198A patent/JP3152941B2/ja not_active Expired - Fee Related
- 1997-08-08 WO PCT/IB1997/000978 patent/WO1998008835A1/en active IP Right Grant
- 1997-08-08 CA CA002264549A patent/CA2264549C/en not_active Expired - Fee Related
- 1997-08-08 DE DE69734774T patent/DE69734774D1/de not_active Expired - Lifetime
- 1997-08-08 AT AT97932964T patent/ATE311377T1/de not_active IP Right Cessation
- 1997-08-08 US US09/242,819 patent/US6664258B1/en not_active Expired - Fee Related
- 1997-08-08 AU AU36322/97A patent/AU3632297A/en not_active Abandoned
- 1997-08-08 EP EP97932964A patent/EP0925291B1/de not_active Expired - Lifetime
- 1997-08-08 IL IL12805097A patent/IL128050A0/xx unknown
- 1997-08-12 HN HN1997000117A patent/HN1997000117A/es unknown
- 1997-08-19 PE PE1997000731A patent/PE108498A1/es not_active Application Discontinuation
- 1997-08-21 AP APAP/P/1997/001075A patent/AP9701075A0/en unknown
- 1997-08-22 HR HR60/024,797A patent/HRP970455A2/hr not_active Application Discontinuation
- 1997-08-22 AR ARP970103835A patent/AR013836A1/es unknown
- 1997-08-22 CO CO97048585A patent/CO4560554A1/es unknown
- 1997-08-22 PA PA19978436501A patent/PA8436501A1/es unknown
- 1997-08-25 ID IDP972950A patent/ID18076A/id unknown
- 1997-08-25 TN TNTNSN97143A patent/TNSN97143A1/fr unknown
- 1997-08-25 MA MA24775A patent/MA26437A1/fr unknown
- 1997-08-25 ZA ZA977597A patent/ZA977597B/xx unknown
- 1997-08-25 GT GT199700096A patent/GT199700096A/es unknown
-
1999
- 1999-02-05 IS IS4969A patent/IS4969A/is unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HN1997000117A (es) | 1997-12-26 |
| IL128050A0 (en) | 1999-11-30 |
| WO1998008835A1 (en) | 1998-03-05 |
| CO4560554A1 (es) | 1998-02-10 |
| HRP970455A2 (en) | 1998-08-31 |
| JP2000502360A (ja) | 2000-02-29 |
| US6664258B1 (en) | 2003-12-16 |
| DE69734774D1 (de) | 2006-01-05 |
| PE108498A1 (es) | 1999-01-29 |
| PA8436501A1 (es) | 2000-05-24 |
| GT199700096A (es) | 1999-02-16 |
| AR013836A1 (es) | 2001-01-31 |
| AU3632297A (en) | 1998-03-19 |
| CA2264549C (en) | 2004-09-14 |
| IS4969A (is) | 1999-02-05 |
| EP0925291B1 (de) | 2005-11-30 |
| AP9701075A0 (en) | 1997-10-31 |
| ID18076A (id) | 1998-02-26 |
| MA26437A1 (fr) | 2004-12-20 |
| ATE311377T1 (de) | 2005-12-15 |
| TNSN97143A1 (fr) | 2005-03-15 |
| EP0925291A1 (de) | 1999-06-30 |
| JP3152941B2 (ja) | 2001-04-03 |
| CA2264549A1 (en) | 1998-03-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP9901436A3 (en) | N-aminoalkylfluorenecarboxamides as dopamine receptor subtype ligands | |
| AU4057097A (en) | Fused indolecarboxamides: dopamine receptor subtype specific ligands | |
| HUP0104666A3 (en) | Thyroid receptor ligands | |
| HU9601529D0 (en) | Pyrimidinedion-, pyrimidinetrion-, triazinedion-, tetrahydro-quinazolinedion- derivatives as alpha-adrenerg receptor antagonists | |
| HU9603525D0 (en) | Vironectin receptor antagonists | |
| AU8096798A (en) | Dopamine d4 receptor ligands | |
| AU2738297A (en) | Tricyclic aminoalkylcarboxamides; novel dopamine d3 receptor subtype specific ligands | |
| HK1019737A1 (en) | Benzoxazinone dopamine d4 receptor antagonists | |
| HK1038749A1 (zh) | 2-哌嗪烷基氨苯並吡咯衍生物:多巴胺受體亞型特異配體 | |
| EP0993829A4 (de) | Transdermale zusammenstellung mit serotoninrezeptor-antagonist | |
| IL128050A0 (en) | Spirocyclic dopamine receptor subtype ligands | |
| AU4312396A (en) | Five-membered heteroaromatic compounds as dopamine receptor subtype ligands | |
| GB9704376D0 (en) | Tetrahydropyridine derivatives as dopamine receptor subtype ligands | |
| AU2248195A (en) | Opiate receptor ligands | |
| SG70655A1 (en) | New spirocyclic compounds | |
| AU1286399A (en) | 3-aminoalkylamino- 2h-1,4-benzoxazines and 3-aminoalkylamino- 2h-1,4-benzothiazines: dopamine receptor subtype specific ligands | |
| AU2459597A (en) | N-aminoalkyl-2-anthraquinonecarboxamides; new dopamine receptor subtype specific ligands | |
| AU6230698A (en) | Dopamine d4 receptor antagonist | |
| AU2335797A (en) | Novel n-aminoalkyl-2-anthracenecarboxamides; new dopamine receptor subtype specific ligands | |
| AU4867496A (en) | Certain bridged 4-phenyl-2-aminomethylimidazoles; new dopamine receptor subtype specific ligands | |
| GB9703382D0 (en) | Tetrahydropyridine derivatives as dopamine receptor subtype ligands | |
| AU4420296A (en) | Aminomethyl aryl compounds; dopamine receptor subtype selective ligands | |
| AU4337599A (en) | Substituted 1-aryl-3-benzylaminopyrrolidine: dopamine receptor subtype specific ligands | |
| EP0914610A4 (de) | Nachweis von ecdyson-rezeptorliganden | |
| HK1038887A1 (zh) | C3a受體配基 |